We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We may also share information about your use of our site with our social media, advertising and analytics partners. Read more about our Privacy Policy.

I got it!

Annual Bispecific Antibody Lisbon Summit

The Curtis & Wyss Group is pleased to invite you to the, Annual Bispecific antibody Lisbon summit, scheduled on March 23-24, 2017 in Lisbon, Portugal.

This premier B2B event will focussed completely on the development of bispecifics Antibody, the Annual Bispecific antibody Lisbon summit represents a unique opportunity to engage with your peers to discuss strategies to overcome the key challenges holding back progress in the field. 

Built using insights from experts, this year’s Bispecific Antibody Lisbon summit will incorporate more developmental and clinical insights than ever before. Rather than presenting vague overviews of platforms, this meeting will delve directly into the technical and scientific insights that will enable you to advance your candidate therapeutic into the clinic as efficiently and cost-effectively as possible. 

 

Key Practical Learning Points of the Summit: 

  • Optimize early decision makingto guarantee target synergy early in the development of multispecific therapeutics, with insights into Sanofi’s novel bispecific development programs
  • Validate bispecific formats in comparison with monoclonal approachesby learning from innovative analytical approaches, including Janssen’s dual binding and single target assays
  • Understand how Pfizer have enhanced bispecific IgG generation by bypassing the need for post purification recombination processes
  • Improve translatability into the clinic by investigating how Immunocore maximize the predictability of in vitro models
  • Investigate novel multispecific approaches for applications spanning beyond oncology, including in- depth case studies into innovative bispecific programs in autoimmune, neurodegenerative and infectious disease indications
  • Determine the characteristics required to ensure clinical success by examining key factors from clinical bispecific programs at Merrimack, Amgen and Macrogenics
  • Leave World Bispecific with clear insights that will dramatically improve the success of your bispecific development

 

WHY should you be there?

CEO, CSO, VP, Director, Head and Scientists in: 

  • Bispecifics
  • Antibody/Biologics
  • R&D
  • Therapeutic Areas
  • Discovery
  • Target ID & Validation
  • Process Development
  • Manufacturing/CMC
  • Bioanalysis
  • PKPD/ADME/Tox
  • Clinical Development
  • Business Development

When

23 Mar 2017 @ 08:30 am

24 Mar 2017 @ 05:00 pm

Duration: 1 days, 8 hours

Where

Lisbon

Lisbon

13000 Lisbon

Portugal

Organised by

Curtis Wyss

+420 226 218 050

Premium Events in Biotechnology

Recent Publications in Biotechnology

Recent Videos in Biotechnology

Recent News in Biotechnology

Would tech be different if women made up half the workforce? Three women in tech share their thoughts.#womenintech… https://t.co/mPVsguFxd2

@garybridgeman - 20 Nov 2017 09:42

Are you ready for #H2020Energy project of the week? @SmartEnCity is working to make European cities greener & smart… https://t.co/3C9kb10Buc

@inea_eu - 20 Nov 2017 08:42

#H2020 funding made it possible our ECHOES project "Energy CHOices supporting the Energy union and the Set plan"… https://t.co/TyMP0MT5ln

@EU_H2020 - 20 Nov 2017 08:41

Recent Speakers in Biotechnology